Immunosensitization with a Bcl-2 small molecule inhibitor. [electronic resource]
Producer: 20090401Description: 699-708 p. digitalISSN:- 1432-0851
- Animals
- Antigens, Neoplasm -- immunology
- Apoptosis -- drug effects
- Biphenyl Compounds -- therapeutic use
- Cancer Vaccines -- immunology
- Cell Line, Tumor -- drug effects
- Colonic Neoplasms -- immunology
- Cytotoxicity, Immunologic
- Dendritic Cells -- immunology
- Drug Screening Assays, Antitumor
- Humans
- Immunotherapy -- methods
- Immunotherapy, Adoptive
- Intramolecular Oxidoreductases -- genetics
- Killer Cells, Lymphokine-Activated -- transplantation
- Listeria monocytogenes -- immunology
- Melanoma, Experimental -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neoplasm Proteins -- antagonists & inhibitors
- Nitrophenols -- therapeutic use
- Piperazines -- therapeutic use
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Receptors, Death Domain -- agonists
- Recombinant Fusion Proteins -- immunology
- Sulfonamides -- therapeutic use
- TNF-Related Apoptosis-Inducing Ligand -- pharmacology
- Tumor Necrosis Factor-alpha -- pharmacology
- fas Receptor -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.